• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[脑膜炎球菌疫苗的疗效、安全性和成本效益]

[Efficacy, safety, and cost-effectiveness of meningococcal vaccines].

出版信息

Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Feb 10;40(2):129-135. doi: 10.3760/cma.j.issn.0254-6450.2019.02.002.

DOI:10.3760/cma.j.issn.0254-6450.2019.02.002
PMID:30744260
Abstract

Meningococcal meningitis is an acute, severe respiratory infectious disease caused by . Immunization with meningococcal vaccine is the most effective measure to control and prevent transmission of meningococcal meningitis. Meningococcal vaccines in the Chinese market include meningococcal polysaccharide vaccine, meningococcal polysaccharide conjugate vaccine, and a combined vaccine containing meningococcal polysaccharide conjugate vaccine. This article reviews research progress on the efficacy, safety, and cost-effectiveness of meningococcal vaccines, particularly in the Chinese market, to support appropriate use of the various meningococcal vaccines for preventing meningococcal meningitis.

摘要

脑膜炎球菌性脑膜炎是一种由……引起的急性、严重呼吸道传染病。接种脑膜炎球菌疫苗是控制和预防脑膜炎球菌性脑膜炎传播的最有效措施。中国市场上的脑膜炎球菌疫苗包括脑膜炎球菌多糖疫苗、脑膜炎球菌多糖结合疫苗以及一种含有脑膜炎球菌多糖结合疫苗的联合疫苗。本文综述了脑膜炎球菌疫苗在疗效、安全性和成本效益方面的研究进展,特别是在中国市场的情况,以支持合理使用各种脑膜炎球菌疫苗来预防脑膜炎球菌性脑膜炎。

相似文献

1
[Efficacy, safety, and cost-effectiveness of meningococcal vaccines].[脑膜炎球菌疫苗的疗效、安全性和成本效益]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Feb 10;40(2):129-135. doi: 10.3760/cma.j.issn.0254-6450.2019.02.002.
2
[Efficacy, safety, and cost-effectiveness of meningococcal vaccines].[脑膜炎球菌疫苗的疗效、安全性及成本效益]
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):146-152. doi: 10.3760/cma.j.issn.0253-9624.2019.02.005.
3
Update on the use of meningococcal serogroup C CRM₁₉₇-conjugate vaccine (Meningitec) against meningitis.关于脑膜炎奈瑟菌 C 群 CRM₁₉₇ 结合疫苗(Meningitec)在脑膜炎预防中的应用的最新进展。
Expert Rev Vaccines. 2016;15(1):9-29. doi: 10.1586/14760584.2016.1115726. Epub 2015 Nov 26.
4
Single priming dose of meningococcal group C conjugate vaccine (NeisVac-C®) in infants.婴儿单剂初免剂量的C群脑膜炎球菌结合疫苗(NeisVac-C®)
Vaccine. 2013 Aug 2;31(35):3611-6. doi: 10.1016/j.vaccine.2013.04.070. Epub 2013 May 11.
5
A randomized trial to assess safety and immunogenicity of alternative formulations of a quadrivalent meningococcal (A, C, Y, and W-135) tetanus protein conjugate vaccine in toddlers.一项评估幼儿使用不同配方的四价脑膜炎球菌(A、C、Y 和 W-135)结合破伤风蛋白疫苗的安全性和免疫原性的随机试验。
Pediatr Infect Dis J. 2012 Jan;31(1):e15-23. doi: 10.1097/INF.0b013e31823e1e34.
6
Immunogenicity and safety of MenACWY-TT, a meningococcal conjugate vaccine, co-administered with routine childhood vaccine in healthy infants: A phase III, randomized study.A 期、随机对照、III 期临床试验研究:在健康婴儿中,结合使用常规儿童疫苗接种,评估 MenACWY-TT(脑膜炎球菌结合疫苗)的免疫原性和安全性。
Vaccine. 2018 Jun 27;36(28):4102-4111. doi: 10.1016/j.vaccine.2018.05.046. Epub 2018 May 18.
7
Early clinical experience with a candidate meningococcal B recombinant vaccine (rMenB) in healthy adults.一种候选B群脑膜炎球菌重组疫苗(rMenB)在健康成年人中的早期临床经验。
Hum Vaccin. 2011 Jul;7(7):781-91. doi: 10.4161/hv.7.7.15997. Epub 2011 Jul 1.
8
Prospects and challenges with introduction of a mono-valent meningococcal conjugate vaccine in Africa.在非洲引入单价脑膜炎球菌结合疫苗的前景与挑战。
Vaccine. 2009 Mar 23;27(14):2023-9. doi: 10.1016/j.vaccine.2008.11.092. Epub 2008 Dec 16.
9
[Experts' consensus on immunization with meningococcal vaccines in China].[中国脑膜炎球菌疫苗免疫专家共识]
Zhonghua Liu Xing Bing Xue Za Zhi. 2019 Feb 10;40(2):123-128. doi: 10.3760/cma.j.issn.0254-6450.2019.02.001.
10
[Experts' consensus on immunization with meningococcal vaccines in China].《中国脑膜炎球菌疫苗免疫专家共识》
Zhonghua Yu Fang Yi Xue Za Zhi. 2019 Feb 6;53(2):141-145. doi: 10.3760/cma.j.issn.0253-9624.2019.02.004.